PTCT PTC Therapeutics, Inc.
63.23USD-0.74%Mkt Cap: 5.28B $P/E: —1d ago
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. T…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap5.28B USD
Enterprise Value6.11B USD
Revenue (TTM)1.01B USD
Gross Profit1.68B USD
Net Income (TTM)682.64M USD
Revenue/Share12.35 USD
Last Price63.23 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees991
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)23.80
PEG—
EV/EBITDA35.66
EV/Revenue6.05
P/S5.27
P/B-32.09
EPS (TTM)-0.65
EPS (Forward)2.68
52W Range
57.7417% of range90.86
52W High90.86 USD
52W Low57.74 USD
Profitability
Gross Margin97.28%
Oper. Margin41.32%
EBITDA Margin16.97%
Profit Margin39.44%
ROE-332.49%
ROA23.55%
Growth
Revenue Growth101.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF711.20M USD
CapEx (TTM)300.01M USD
FCF Margin-28.43%
FCF Yield-5.43%
Net Debt788.82M USD
Net Debt/EBITDA4.61
Balance Sheet
Debt/Equity-13.19
Current Ratio3.39
Quick Ratio3.20
Book Value/Sh-1.99 USD
Cash/Share26.71 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)101.79 USD
Upside (mean)+61.0%
Target Range70.00 USD – 137.00 USD
70.00+61.0% to mean137.00
# Analysts14
Ownership
Shares Out.83.46M
Float73.69M
Insiders7.31%
Institutions122.79%
Short Interest
Short Ratio11.4d
Short % Float15.82%
Short % Out.11.67%
Shares Short9.74M
Short (prev mo.)10.22M
Technical
SMA 5069.28 (-8.7%)
SMA 20072.10 (-12.3%)
Beta0.49
S&P 52W Chg16.45%
Avg Vol (30d)1.12M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)36.4
MACD-1.9896
MACD Signal-2.1459
MACD Hist.+0.1563
BB Upper69.29 USD
BB Middle65.19 USD
BB Lower61.08 USD
BB Width12.59%
ATR (14)2.186 USD
Vol Ratio (20d)0.83x